Clinical Outcome of Patients with Heart Failure and Preserved Left Ventricular Function

American Journal of Medicine

Volumn 121, Issue 11, 2008, Pages 997-1001

  Gotsman, Israel ^a   Zwas, Donna ^a   Planer, David ^a   Azaz Livshits, Tanya ^a   Admon, Dan ^a   Lotan, Chaim ^a   Keren, Andre ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Heart failure; Outcome; Preserved left ventricular function; Survival

Indexed keywords

ACETYLSALICYLIC ACID; ALDOSPIRONE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRATE; SODIUM; SPIRONOLACTONE; UNCLASSIFIED DRUG;

AGED; ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL ASSESSMENT; CLINICAL TRIAL; COMPARATIVE STUDY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DIABETES MELLITUS; ECHOCARDIOGRAPHY; FEMALE; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE FUNCTION; HOSPITAL PATIENT; HOSPITAL READMISSION; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; NURSING HOME; OUTCOME ASSESSMENT; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; SODIUM BLOOD LEVEL; SURVIVAL; SYMPTOM; SYSTOLE;

AGED; AGED, 80 AND OVER; FEMALE; HEART FAILURE; HUMANS; ISRAEL; MALE; MIDDLE AGED; PROGNOSIS; VENTRICULAR FUNCTION, LEFT;

EID: 54349088212     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2008.06.031     Document Type: Article

References (17)

1. Owan T.E., Hodge D.O., Herges R.M., et al. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med 355 (2006) 251-259
2. Bhatia R.S., Tu J.V., Lee D.S., et al. Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med 355 (2006) 260-269
3. Bursi F., Weston S.A., Redfield M.M., et al. Systolic and diastolic heart failure in the community. JAMA 296 (2006) 2209-2216
4. Tribouilloy C., Rusinaru D., Mahjoub H., et al. Prognosis of heart failure with preserved ejection fraction: a 5 year prospective population-based study. Eur Heart J 29 (2008) 339-347 Epub 2007 Dec 22
5. Berry C., Hogg K., Norrie J., et al. Heart failure with preserved left ventricular systolic function: a hospital cohort study. Heart 91 (2005) 907-913
6. Varela-Roman A., Grigorian L., Barge E., et al. Heart failure in patients with preserved and deteriorated left ventricular ejection fraction. Heart 91 (2005) 489-494
7. Lenzen M.J., Scholte op Reimer W.J., et al. Differences between patients with a preserved and a depressed left ventricular function: a report from the EuroHeart Failure Survey. Eur Heart J 25 (2004) 1214-1220
8. Masoudi F.A., Havranek E.P., Smith G., et al. Gender, age, and heart failure with preserved left ventricular systolic function. J Am Coll Cardiol 41 (2003) 217-223
9. Gustafsson F., Torp-Pedersen C., Brendorp B., et al. Long-term survival in patients hospitalized with congestive heart failure: relation to preserved and reduced left ventricular systolic function. Eur Heart J 24 (2003) 863-870
10. Fonarow G.C., Stough W.G., Abraham W.T., et al. Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF Registry. J Am Coll Cardiol 50 (2007) 768-777
11. Tsutsui H., Tsuchihashi M., and Takeshita A. Mortality and readmission of hospitalized patients with congestive heart failure and preserved versus depressed systolic function. Am J Cardiol 88 (2001) 530-533
12. Zile M.R., Gaasch W.H., Carroll J.D., et al. Heart failure with a normal ejection fraction: is measurement of diastolic function necessary to make the diagnosis of diastolic heart failure?. Circulation 104 (2001) 779-782
13. Yusuf S., Pfeffer M.A., Swedberg K., et al. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial. Lancet 362 (2003) 777-781
14. Lonn E., Shaikholeslami R., Yi Q., et al. Effects of ramipril on left ventricular mass and function in cardiovascular patients with controlled blood pressure and with preserved left ventricular ejection fraction: a substudy of the Heart Outcomes Prevention Evaluation (HOPE) Trial. J Am Coll Cardiol 43 (2004) 2200-2206
15. Lewis B.S., Shotan A., Gottlieb S., et al. Late mortality and determinants in patients with heart failure and preserved systolic left ventricular function: the Israel Nationwide Heart Failure Survey. Isr Med Assoc J 9 (2007) 234-238
16. Solomon S.D., Anavekar N., Skali H., et al. Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients. Circulation 112 (2005) 3738-3744
17. Smith G.L., Masoudi F.A., Vaccarino V., et al. Outcomes in heart failure patients with preserved ejection fraction: mortality, readmission, and functional decline. J Am Coll Cardiol 41 (2003) 1510-1518